Journal of General Internal Medicine

, Volume 29, Issue 4, pp 602–607 | Cite as

Race/Ethnicity, Disability, and Medication Adherence Among Medicare Beneficiaries with Heart Failure




Recent and national data on adherence to heart failure drugs are limited, particularly among the disabled and some small minority groups, such as Native Americans and Hispanics.


We compare medication adherence among Medicare patients with heart failure, by disability status, race/ethnicity, and income.


Observational study.


US Medicare Parts A, B, and D data, 5 % random sample, 2007–2009.


149,893 elderly Medicare beneficiaries and 21,204 disabled non-elderly beneficiaries.


We examined 5 % of Medicare fee-for-service beneficiaries with heart failure in 2007–2009. The main outcome was 1-year adherence to one of three therapeutic classes: β-blockers, diuretics, and angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin II receptor blockers (ARBs). Adherence was defined as having prescriptions in possession for ≥ 75 % of days.


Among aged beneficiaries, 1-year adherences to at least one heart failure drug were 63 %, 57 %, 53 %, 50 %, and 52 % for Whites, Asians, Hispanics, Native Americans and Blacks, respectively; among the disabled, 1-year adherence was worse for each group: 57 %, 53 %, 48 %, 44 % and 43 % respectively. The racial/ethnic difference persisted after adjustment for age, gender, income, drug coverage, location and health status. Patterns of adherence were similar among beneficiaries on all three therapeutic classes. Among beneficiaries with close-to-full drug coverage, minorities were still less likely to adhere relative to Whites, OR = 0.61 (95 % CI 0.58–0.64) for Hispanics, OR = 0.59 (95 % CI 0.57–0.62) for Blacks and OR = 0.57 (95 % CI 0.47–0.68) for Native Americans.


After the implementation of Medicare Part D, adherence to heart failure drugs remains problematic, especially among disabled and minority beneficiaries, including Native Americans, Blacks, and Hispanics. Even among those with close-to-full drug coverage, racial differences remain, suggesting that policies simply relying on cost reduction cannot eliminate racial differences.


racial disparity Medicare heart failure medication adherence disability 


  1. 1.
    American Heart Association. Heart and Stroke Statistical Update. Dallas: American Heart Association 2006; 2006.Google Scholar
  2. 2.
    Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):1977–2016. doi:10.1161/circulationaha.109.192064.PubMedCrossRefGoogle Scholar
  3. 3.
    Wu J-R, Moser DK, Chung ML, Lennie TA. Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. J Card Fail. 2008;14(3):203–10.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80 %. BMJ. 2003;326(7404):1419.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Newby LK, Allen LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113(2):203–12. doi:10.1161/circulationaha.105.505636.PubMedCrossRefGoogle Scholar
  6. 6.
    Choudhry NK, Avorn J, Glynn RJ, et al. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011;365(22):2088–97. doi:10.1056/NEJMsa1107913.PubMedCrossRefGoogle Scholar
  7. 7.
    Stroupe KT, Teal EY, Weiner M, Gradus-Pizlo I, Brater DC, Murray MD. Health care and medication costs and use among older adults with heart failure. Am J Med. 2004;116(7):443–50.PubMedCrossRefGoogle Scholar
  8. 8.
    Zhang Y, Wu S, Fendrick AM, Baicker K. Variation in medication adherence in heart failure. JAMA Intern Med. 2013:1–2. doi:10.1001/jamainternmed.2013.2509
  9. 9.
    Neuman P, Strollo MK, Guterman S, et al. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors. Health Aff. 2007;26(5):w630–43. doi:10.1377/hlthaff.26.5.w630.CrossRefGoogle Scholar
  10. 10.
    Zhang Y, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care. 2010;48(5):409–17. doi:10.1097/MLR.0b013e3181d68978.PubMedCrossRefGoogle Scholar
  11. 11.
    Institute of Medicine. Geographic Variation in Health Care Spending and Promotion of High-Value Care - Interim Report. IOM. 2013. Accessed October 21, 2013.
  12. 12.
    Bonito A, Bann C, Eicheldinger C, Carpenter L. Creation of new race-ethnicity codes and Socioeconomic Status (SES) indicators for medicare beneficiaries. Final Report. Sub-Task 2. (Prepared by RTI International for the Centers for Medicare and Medicaid Services through an interagency agreement with the Agency for Healthcare Research and Policy, under Contract No. 500-00-0024, Task No. 21). Agency for Healthcare Research and Quality, Rockville, MD. 2008. Accessed October 21, 2013.
  13. 13.
    Zhang Y, Baik SH, Chang CC, Kaplan CM, Lave JR. Disability, race/ethnicity, and medication adherence among Medicare myocardial infarction survivors. Am Heart J. 2012;164(3):425–33 e4. doi:10.1016/j.ahj.2012.05.021.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Kaiser Family Foundation. Low-income assistance under the Medicare drug benefit. Menlo Park, CA, USA. 2009. Accessed October 21, 2013.
  15. 15.
    Zhang Y, Baik SH, Fendrick AM, Baicker K. Comparing local and regional variation in health care spending. N Engl J Med. 2012;367(18):1724–31. doi:10.1056/NEJMsa1203980.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Centers for Medicare & Medicaid Services. 2011 Model diagnosis and model softweare—RxHCC model software. Centers for Medicare & Medicaid Services, Baltimore, MD, USA. 2011. Accessed October 21, 2013.
  17. 17.
    Davis AM, Vinci LM, Okwuosa TM, Chase AR, Huang ES. Cardiovascular health disparities: a systematic review of health care interventions. Med Care Res Rev. 2007;64(5 Suppl):29S–100S.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Lewey J, Shrank WH, Bowry AD, Kilabuk E, Brennan TA, Choudhry NK. Gender and racial disparities in adherence to statin therapy: a meta-analysis. Am Heart J. 2013;165(5):665–78 e1. doi:10.1016/j.ahj.2013.02.011.PubMedCrossRefGoogle Scholar
  19. 19.
    Bagchi AD, Esposito D, Kim M, Verdier J, Bencio D. Utilization of, and adherence to, drug therapy among Medicaid beneficiaries with congestive heart failure. Clin Ther. 2007;29(8):1771–83.PubMedCrossRefGoogle Scholar
  20. 20.
    Zhang Y, Gellad WF, Zhou L, Lin Y-J, Lave JR. Access to and use of $4 Generic Programs in Medicare. J Gen Intern Med. 2012;27(10):1251–7.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Wijeysundera HC, Machado M, Farahati F, et al. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994–2005. JAMA. 2010;303(18):1841–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Zhang Y, Donohue JM, Lave JR, O’Donnell G, Newhouse JP. The effect of Medicare Part D on drug and medical spending. N Engl J Med. 2009;361(1):52–61. doi:10.1056/NEJMsa0807998.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Hsu J, Price M, Huang J, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354(22):2349–59.PubMedCrossRefGoogle Scholar
  24. 24.
    Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–67.PubMedCrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2013

Authors and Affiliations

  1. 1.Department of Health Policy and Management, Graduate School of Public HealthUniversity of PittsburghPittsburghUSA

Personalised recommendations